Navigation Links
Tegra Medical Announces New President/CEO

FRANKLIN, Mass., May 17, 2012 /PRNewswire/ -- Tegra Medical is pleased to announce that Robert E. Pietrafesa has joined the company as President and Chief Executive Officer.

"We're thrilled to have Rob join the organization to lead the Tegra team," said David Belluck, Chairman of the Board at Tegra and General Partner of Riverside Partners, the majority owner of Tegra Medical. "Tegra is well positioned to serve the growing medical device outsourcing market with a terrific set of manufacturing capabilities and a dedicated workforce. Attracting a seasoned leader with Rob's broad industry knowledge and operating experience is exactly what's needed to ensure that our strategy and execution are well aligned."

Rob brings more than 16 years of experience as a President and Chief Operating Officer in medical device manufacturing; he has also held executive leadership positions in the clothing manufacturing and wholesale book industries. Most recently, Rob served as President of the InterV Division of Angiotech Pharmaceuticals after the successful sale of American Medical Instruments (AMI) to Angiotech for $785 million. During the three prior years, while he was President at the InterV Division of AMI, the firm's revenues tripled and operating income increased by 500 percent. 

Earlier, Rob was a Group Vice President of Medical for the $6.2 billion Marmon Group. There, he served as chief strategist of the medical business and led the acquisition of five companies in six years. He then orchestrated a successful spinoff of most of the medical assets to create a branded device company principally owned by the private equity firm Roundtable Healthcare Partners, with Marmon continuing as an investor. In 1992 Rob assumed the leadership of B.G. Sulzle as Executive Vice President and COO. In five years, Sulzle grew revenue by $28 million by improving quality, reducing lead times dramatically and increasing exports of surgical needles from 25 percent to 65 percent of sales, becoming the world's largest independent manufacturers of surgical needles.  In 1997 the company was sold to The Marmon Group.

"I've known Tegra and some of its key principals for a number of years and have always admired the technical prowess, the focus on solving customer problems, and the character and integrity of the team," said Pietrafesa. "I look forward to leveraging this strong foundation and ensuring that we build on past successes with an unrelenting focus on customer satisfaction. Tegra has a committed and talented workforce. With the GENESIS Tech Center® to prototype and develop manufacturing processes, a low cost country option with our operation in Costa Rica, and the sophisticated quality system and practices required today, Tegra has the right offering to meet the needs of the most demanding device manufacturers."

About Tegra Medical
Tegra Medical is focused exclusively on the medical device industry, providing precision machining and contract manufacturing services. Tegra uses a wide range of manufacturing technologies to produce complex components and finished devices used in cutting-edge procedures for leading surgical, interventional and orthopaedic companies.  Tegra has 200,000 sq. ft. of modern manufacturing space in four locations and is ISO 13485:2003 registered. The company combines a broad spectrum of capabilities with a can-do culture to deliver exceptional solutions, speed and service.

About Riverside Partners
Founded in 1989, Riverside Partners is a middle market private equity firm currently investing Riverside Fund IV, L.P. The fund focuses on growth oriented companies primarily in the healthcare and technology industries. Riverside is particularly experienced at partnering with founders, owners and management teams and it brings substantial domain expertise and operating experience to its portfolio companies. The partners at Riverside have managed more than $500 million in investments in over 50 companies. The firm is currently focused on companies with revenues between $20 and $200 million and with $5-$25 million of EBITDA.

Tegra Medical
Tom Burns


SOURCE Tegra Medical
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Viztek Announces Availability of Opal-Mammo Integrated Mammography Suite - Complete Womens Health Package Combines PACS and Tracking Software
2. Practice Fusion Launches API to Democratize Lab Integrations
3. Study Finds Utilizing Integrated Medical and Pharmacy Data Improves Ability to Forecast Use of High-cost Specialty Treatments
4. Olympus Introduces the Worlds Only Integrated Bipolar and Ultrasonic Energy Platform
5. Psyche Systems Corporation and Aperio® Announce Availability of Their Fully Integrated Anatomic Pathology System
6. BioStorage Technologies Integrates Sample Preparation Services into European Operations
7. Brainlab Partners With Radion to Integrate VoyantLink Image Sharing Into One Streamlined Solution for Radiation Therapy Centers
8. Elsevier Integrates its Clinical Decision Support Solutions Into PatientKeeper CPOE
9. Newsbyte: SAP to Integrate Healthcare in the Community Through Collaborative Care
10. Allscripts and MyCareTeam Launch Integrated Diabetes Management Solution
11. Synthetic Genomics, Inc. and Integrated DNA Technologies, Inc. Sign Agreement to Manufacture, Market, and Commercialize Small Synthetic Gene Products Using SGI Technology
Post Your Comments:
(Date:12/1/2015)...  Athletic apparel company Tommie Copper , ... $1.35 million to settle Federal Trade Commission charges ... clothing would relieve severe and chronic pain and ... Tommie Copper,s proposed settlement with ... founder and chairman Thomas Kallish to ...
(Date:12/1/2015)... , 1 de diciembre de 2015 /PRNewswire/ ... para cuchillas de precisión, develó hoy un ... identidad de marca. El nuevo logo destaca ... y la ingeniería de productos con cuchillas ... ...
(Date:12/1/2015)... PUNE, India , December 1, 2015 ... to a new market research report "Nucleic Acid Labeling ... Techniques (PCR, Nick Translation, Random Primer, In Vitro Transcription, ... to 2020", published by MarketsandMarkets, The global market is ... USD 1,271.8 Million in 2015, growing at a CAGR ...
Breaking Medicine Technology:
(Date:12/1/2015)... ... December 02, 2015 , ... ... Gastrointestinal events and association with initiation of treatment for osteoporosis ”. , As ... of pharmacological treatment in patients diagnosed with osteoporosis. Based on a large US ...
(Date:12/1/2015)... , ... December 01, 2015 , ... According to an ... groups has filed a discrimination claim against the U.S. Department of Health and Human ... Affordable Care Act (ACA) plans are breaking the clause in the law prohibiting the ...
(Date:12/1/2015)... Houston, TX (PRWEB) , ... December 01, 2015 , ... ... owner of Vitenas Cosmetic Surgery, has been named by MedEsthetics magazine as the Best ... best of the best among the many elite aesthetic physicians honored by the industry ...
(Date:12/1/2015)... ... December 01, 2015 , ... December 1, 2015—Since ... improvements in scientific research and discoveries, leading us to better understand the disease’s ... to those affected by HIV/AIDS. Mediaplanet’s cross-platform edition of “World AIDS Day” provides ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... the United States. Podiatrists are well aware that psychology-based patient non-compliance (disobedience of ... often catastrophic contributors to diseases of the diabetic foot. The American Board ...
Breaking Medicine News(10 mins):